MedTrace Logo

Predicting Esophageal Cancer Borders Using PET-Imaging

NCT06408116 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-03-10

No results posted yet for this study

Summary

The study examines the diagnostic precision of endosonography, mpMRI and PET/CT in defining tumor boundaries and tumor spread before and after neoadjuvant therapy and definitive surgery.

Conditions

  • Esophagus Cancer, Stage I
  • Esophagus Cancer, Stage II

Interventions

RADIATION

photon

radiation with 4-5 cm safte margin

PROCEDURE

surgical therapy

surgery based on PET-CT/MRI staging

DRUG

Chemotherapy

neoadjuvant chemotherapy

Sponsors & Collaborators

  • University Hospital Heidelberg

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2028-01-31
Completion
2028-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06408116 on ClinicalTrials.gov